Skip to main content

Table 4 Changes from baseline in anthropometric, fasting and postprandial parameters at the end of PUFA supplementation in two different PPAR genotypes

From: Influence of different CLA isomers on insulin resistance and adipocytokines in pre-diabetic, middle-aged men with PPARγ2 Pro12Ala polymorphism

Preparation

PPARγ2 Pro12Pro homozygous (n = 23)

PPARγ 2 Ala12Ala homozygous (n = 12)

Linoleic acid from safflower oil

Tonalin FFA (50:50 mix)

Cis-9, trans-11 CLA

Trans-10, cis-12 CLA

Linoleic acid from safflower oil

Tonalin FFA 80 (50:50 mix)

Cis-9, trans-11 CLA

Trans-10, cis-12 CLA

p-Value between genotypes

p-Value preparation

Anthropometry

Δ Weight (kg)

0.7 (±0.4)

0.7 (±0.4)

0.4 (±0.5)

−0.1 (±0.5)

−0.2 (±0.4)

−0.1 (±0.4)

0.2 (±0.6)

0.7 (±0.2)

ns

ns

Δ BMI (kg/m2)

0.2 (±0.1)

0.2 (±0.1)

0.1 (±0.2)

0.0 (±0.2)

−0.1 (±0.1)

0.0 (±0.1)

0.1 (±0.2)

0.1 (±0.2)

ns

ns

Δ Waist (cm)

1.3 (±0.4)

1.2 (±0.4)

1.4 (±0.7)

0.0 (±0.6)

0.9 (±0.8)

1.3 (±0.5)

1.3 (±0.7)

1.3 (±0.7)

ns

ns

Δ Hip (cm)

−0.3 (±0.5)

−0.3 (±0.5)

−0.5 (±0.6)

−1.0 (±0.5)

−0.4 (±0.6)

−0.5 (±0.7)

0.0 (±0.5)

−0.5 (±0.6)

ns

ns

Δ Waist/hip ratio

0.0 (±0.0)

0.0 (±0.0)

0.0 (±0.0)

0.0 (±0.0)

0.0 (±0.0)

0.0 (±0.0)

0.0 (±0.0)

0.0 (±0.0)

ns

ns

Fasting

Δ Plasma glucose (mg/dl)

−2.6 (±1.5)

−0.3 (±1.4)

−0.8 (±1.2)

−2.0 (±1.5)

−0.4 (±1.6)

−0.1 (±1.8)

−1.1 (±2.1)

−1.6 (±0.9)

ns

ns

Δ Serum insulin (μU/ml)

1.2 (±0.8)a

2.1 (±0.7)a

1.2 (±0.7)a

0.9 (±0.7)a

3.8 (±1.2)b

3.3 (±1.4)b

4.0 (±1.0)b

3.7 (±0.9)b

p ≤ 0.001*

ns

Δ HOMA−IR

0.3 (±0.2)a

0.5 (±0.2)a

0.3 (±0.2)a

0.2 (±0.2)a

0.9 (±0.3)b

0.8 (±0.3)b

0.9 (±0.3)b

0.8 (±0.2)b

p ≤ 0.002*

ns

Δ Triacylglycerols (mg/dl)

3.9 (±6.2)

7.7 (±7.9)

−1.1 (±7.8)

7.3 (±6.3)

12.0 (±6.2)

−2.8 (±19.5)

−5.7 (±11.6)

−1.2 (±11.4)

ns

ns

Δ Adiponectin (ng/ml)

−245 (±120)

−35 (±126)

109 (±189)

−372 (±186)

103 (±233)

44 (±329)

91 (±223)

−123 (±470)

ns

ns

Δ Plasma leptin (pg/ml)

−1,116.8 (±580)a

−1,680.5 (±610)a

−1,363 (±499)a

−2,031 (±506)a

−82 (±509)b

58 (±650)b

310 (±419)b

−166 (±412)b

p ≤ 0.000*

ns

Postprandial

Δ Glucose AUC (mg/dl)

7.7 (±8.7)

6.3 (±8.4)

−4.8 (±9.2)

7.7 (±10.2)

0.3 (±8.1)

7.3 (±13.7)

−6.8 (±11.2)

8.8 (±10.0)

ns

ns

Δ Insulin AUC (μU/ml)

9.4 (±9.8)a

−0.2 (±6.1)a

2.0 (±9.9)a

6.2 (±10.4)a

55.1 (±17.7)b

20.6 (±15.8)b

34.3 (±11.9)b

65.9 (±20.0)b

p ≤ 0.000*

ns

Δ HOMA−IR AUC

11.7 (±13.8)a

−1.1 (±10.2)a

−3.7 (±14.1)a

10.1 (±16.5)a

67.7 (±22.1)b

29.1 (±22.3)b

39.5 (±16.3)

86.7 (±29.4)b

p ≤ 0.001*

ns

Δ Triacylglycerols (mg/dl)

178 (±118.0)

188 (±134.2)

4.0 (±98.1)

162.7 (±93.7)

73.0 (±152.3)

−61.1 (±119.6)

8.0 (±148.2)

121.2 (±158.4)

ns

ns

Δ Adiponectin 5 h (ng/ml)

−267 (±185)

−83 (±212.6)

−106 (±205)

−258 (±215)

332 (±320)

90 (±392)

211 (±231)

−550 (±292)

ns

ns

Δ Leptin AUC (pg/ml)

−11,718 (±4,526)a

−14,619 (±4,573)a

−12,289 (±4,287)a

−17,436 (±4,297)a

−5,654 (±4,427)b

−2,639 (±4,944)b

−3,367 (±2,992)b

−2,065 (±3,255)b

p ≤ 0.004*

ns

  1. All values are expressed as Δ from baseline value (mean ± SEM)
  2. CLA conjugated linoleic acid, BMI body mass index
  3. * Significant differences between genotype groups (p ≤ 0.05; MANOVA). Duncan’s post hoc test was used to describe where the differences between intervention groups appeared. Means that are significantly different from others are marked as unlike letters